SEC Form 4 · accession 0000899243-15-008132
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Reddish
Director
Period of report
Feb 16, 2011
Accepted (ET)
Nov 13, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2014 | J | 225,000 | $0.80 | A | 226,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $17.00 | Feb 16, 2011 | A | 2,000 | A | Feb 16, 2011 | Feb 16, 2021 | Common Stock | 2,000 | 2,000 | D |
| Employee Stock Option (Right to Buy)F2 | $17.00 | Apr 30, 2012 | A | 2,500 | A | Apr 30, 2012 | Apr 30, 2022 | Common Stock | 2,500 | 4,500 | D |
Explanation of responses
- F1Represents common shares issued by the Company in exchange for cancellation of amounts owed to Mr. Reddish of $180,000 in connection with the Company's restructuring in early 2014 in which Series A preferred was issued for the debt and expense reimbursement and subsequently converted into the common stock.
- F2These options were originally issued prior to the Company's most recent February 2014 1 for 100 reverse stock split and amounts reflected are on a post-split basis. The shares have vested.